MedPath

Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure

Not Applicable
Conditions
Renal Calculi
Interventions
Device: SF-URS with automatic control of RPP
Device: conventional F-URS
Registration Number
NCT02734914
Lead Sponsor
The Affiliated Ganzhou Hospital of Nanchang University
Brief Summary

This study evaluates the safety and efficacy of the suctioning flexible ureteroscopy(SF-URS) with automatic control of renal pelvic pressure for the treatment of upper urinary calculi using a prospective, randomized design. Half of participants will receive suctioning flexible ureteroscopy with automatic control of renal pelvic pressure, while the other half participants will receive retrograde intrarenal surgery using the classic flexible ureteroscopy.

Detailed Description

Retrograde intrarenal surgery using flexible ureteroscope has become the first-line treatment for renal calculi \< 3.0 cm and is recommended by the European Association of Urology due to its minimally-invasive nature and satisfactory result.

However, high perfusion rate leads to renal pelvic pressure increase, resulting in absorption of liquid, bacteria, and endotoxin into blood, followed by short-term complications such as systemic inflammatory response syndrome(SIRS , 8.1%), sepsis (0-4.5%), renal pelvic and ureteral tumor spread, and long-term complication of renal function impairment. Currently the commonly used flexible ureteroscope sheath (ureteral access sheath, UAS) reduces the renal pelvic pressure to a certain extent, but still can not control and monitor the renal pelvic pressure to reduce the incidence of complications, which, limit the clinical application of ureteroscopy.

Recently, the investigators present a novel technique of SF-URS with automatic control of renal pelvic pressure. In this study, transverse comparison is designed to evaluate the safety and efficacy of the suctioning flexible ureteroscopy with automatic control of renal pelvic pressure for the treatment of renal calculi.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subject has provided informed consent and indicated a willingness to comply with study treatments
  • Subject has a diagnosis of renal stones according to computer tomography (CT) results
  • Subject is 18-75 yrs of age
  • Subject has a single stone < 3 cm in size, or multiple stones < 3 cm in cumulative size
  • Subject has a serum creatinine level within the normal range for the study center
Exclusion Criteria
  • The patient who do not agree with the intention of the clinical study.
  • Subject needs bilateral procedures within one-stage ureteroscopy
  • Subject has an active urinary tract infection (e.g., cystitis, prostatitis, urethritis, etc.) and severe hematuria
  • Subject has been diagnosed with a urethral stricture or bladder neck contracture
  • Subject has a disorder of the coagulation cascade system that would put the subject at risk for intraoperative or postoperative bleeding
  • Subject is unable to discontinue anticoagulant and antiplatelet therapy preoperatively (3-5 d)
  • Subject has other diseases and could not tolerate the endoscopic surgery
  • Subject has any kind of anatomic abnormality of the urinary system that might have an influence on the surgery
  • Subject has been diagnosed with hydronephrosis larger than 3 cm according to the B-scan ultrasonography examination

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SF-URS with automatic control of RPPSF-URS with automatic control of RPPParticipants in SF-URS with automatic control of renal pelvic pressure (RPP) group undergo ureteroscopy using the intelligent pressure control device (Medical irrigation and suctioning platform with pressure feedback function, and suctioning ureteral access sheath with function of pressure measuring).
conventional F-URSconventional F-URSParticipants in conventional F-URS group undergo ureteroscopy using the classic flexible ureteroscope.
Primary Outcome Measures
NameTimeMethod
stone-free rate4 weeks post-operatively

Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group \*100%

Secondary Outcome Measures
NameTimeMethod
stone-free rateOne day post-operatively

Number of participants undergo novel or conventional F-URS surgeries without residual calculus/Total number of participants in each group \*100%

Complication ratesWithin 4 weeks after surgery

Number of participants undergo novel or conventional F-URS surgeries suffer complications associated with the surgery (i.e. pain(NRS≥4), hematuria, T≥38℃, serum white blood cell≥12×〖10〗\^9/L ,serum white blood cell\<4×〖10〗\^9/L, perforation, etc.)/Total number of participants in each group \*100%

© Copyright 2025. All Rights Reserved by MedPath